Amedisys Aktie - Fundamentalanalyse - Dividendenrendite KGV

Amedisys (ISIN: US0234361089, WKN: 915582) Kursdatum: 19.06.2018 Kurs: 85,960 USD
Beschreibung Daten
Symbol AMED
Marktkapitalisierung 2.948.771.840,00 USD
Land Vereinigte Staaten von Amerika
Indizes NASDAQ Comp.
Sektor Gesundheitswesen
Rohdaten nach US GAAP in Millionen USD
Aktiensplits 2006-12-05 - 4.0000/3.0000 |
Internet www.amedisys.com
Letztes Bilanz Update 28.02.2018

Fundamentaldaten

Fundamental Verhältnisse errechnet am: 19.06.2018
KFCV KCV DIV Rendite GKR EKQ KGV KUV KBV
31,03 27,89 0,00% 3,71 63,35 97,68 1,92 5,72

Firmenbeschreibung

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and Personal Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses, physical and speech therapists, occupational therapists, and aides for its patients to complete their important personal tasks. The Hospice segment offers care that is designed to provide comfort and support for those who are dealing with a terminal illness, including heart disease, pulmonary disease, Alzheimer\'s, HIV/AIDS, and cancer. The Personal Care segment provides assistance for patients with the activities of daily living. As of February 27, 2018, the company owned and operated 421 care centers in 34 states. Amedisys, Inc. was founded in 1982 and is headquartered in Baton Rouge, Louisiana.

Die Finanzoo GmbH übernimmt keine Haftung für die Richtigkeit der Angaben! Alle Angaben sind ohne Gewähr. Quellen: www.bundesanzeiger.de, www.sec.gov, www.amedisys.com